Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration
PHASE1CompletedINTERVENTIONAL
Enrollment
35
Participants
Timeline
Start Date
December 31, 2005
Study Completion Date
November 30, 2006
Conditions
Rhinoconjunctivitis
Interventions
DRUG
Pollen
Trial Locations (1)
Unknown
University Hospital Zurich, Zurich
All Listed Sponsors
lead
University of Zurich
OTHER
NCT00457444 - Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration | Biotech Hunter | Biotech Hunter